Lymphedema and Quality of Life in Breast Cancer Survivors: The Iowa Women's Health Study
Top Cited Papers
- 10 December 2008
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 26 (35) , 5689-5696
- https://doi.org/10.1200/jco.2008.16.4731
Abstract
Purpose: The impact of lymphedema or related arm symptoms on health-related quality of life (HRQOL) in breast cancer (BrCa) survivors has not been examined using a large population-based cohort.Patients and Methods: The Iowa Women's Health Study (IWHS) collected self-report data for lymphedema, arm symptoms, and HRQOL (Medical Outcomes Study Short Form-36) in 2004 and data for cancer diagnosis, treatment, and behavioral and health characteristics between 1986 and 2003. We studied 1,287 women, age 55 to 69 years at baseline, who developed unilateral BrCa. We used cross-sectional analyses to describe the prevalence of lymphedema and arm symptoms and multivariate-adjusted generalized linear models to compare HRQOL (physical functioning, bodily pain, general health, physical and emotional role limitations, vitality, social functioning, and mental health) between the following three survivor groups: women with lymphedema (n = 104), women with arm symptoms without diagnosed lymphedema (n = 475), and women without lymphedema or arm symptoms (n = 708).Results: The mean (± SE) time between BrCa diagnosis and lymphedema survey was 8.1 ± 0.2 years. Of BrCa survivors, 8.1% self-reported diagnosed lymphedema, and 37.2% self-reported arm symptoms. Knowledge of lymphedema was low among survivors without diagnosed lymphedema (n = 1,183). After multivariate adjustment, women with diagnosed lymphedema or arm symptoms without diagnosed lymphedema had lower physical and mental HRQOL compared with women without lymphedema or arm symptoms. Effect sizes were mild to moderate. There was a dose-response relation between number of arm symptoms and lower HRQOL.Conclusion: In the IWHS, HRQOL was lower for BrCa survivors with diagnosed lymphedema and for those with arm symptoms without diagnosed lymphedema. Clinical trials are needed to determine what interventions can improve lymphedema and impact HRQOL for BrCa survivors.This publication has 39 references indexed in Scilit:
- The Epidemiology of Arm and Hand Swelling in Premenopausal Breast Cancer SurvivorsCancer Epidemiology, Biomarkers & Prevention, 2007
- Assessment of health‐related quality of life in patients with lymphedema of the lower limbWound Repair and Regeneration, 2006
- Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedemaSupportive Care in Cancer, 2005
- Is physical function a more appropriate measure than volume excess in the assessment of breast cancer-related lymphoedema (BCRL)?European Journal Of Cancer, 2003
- A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-related lymphoedemaEuropean Journal of Cancer Care, 2002
- SF-36 Health Survey UpdateSpine, 2000
- The rand 36‐item health survey 1.0Health Economics, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Effect Sizes for Interpreting Changes in Health StatusMedical Care, 1989
- Evaluation of the results of three different methods of postmastectomy lymphedema treatmentJournal of Surgical Oncology, 1984